Comparing different adjuvants for COVID-19 vaccines
ADJUVANT COMPARISON AND CHARACTERIZATION
This study is looking at how different ingredients can boost the effectiveness of COVID-19 vaccines, helping us understand which combinations might give you better protection against the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11159356 on NIH RePORTER |
What this research studies
This research investigates how various adjuvants enhance the immune response when used with COVID-19 vaccines. By comparing these adjuvants side-by-side, the study aims to create detailed immune profiles, known as 'immune fingerprints', that reveal how different adjuvants function in the body. This information could help optimize vaccine formulations to improve their effectiveness against SARS-CoV-2. Patients may benefit from a better understanding of which vaccine combinations could provide stronger immunity.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are eligible for COVID-19 vaccination and are interested in contributing to vaccine development.
Not a fit: Patients who have already received a complete COVID-19 vaccination series may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective COVID-19 vaccines that provide stronger and longer-lasting immunity.
How similar studies have performed: Other research has shown promise in optimizing vaccine adjuvants, indicating that this approach could lead to significant advancements in vaccine efficacy.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Pulendran, Bali — Stanford University
- Study coordinator: Pulendran, Bali
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.